發表時間 文章標題 人氣 留言
2013-08-13 置頂 奈米物質風險管控 宜從上游法規把關 (205) (0)
2013-08-13 置頂 為下一波生物相似性藥品發展鋪路? EMA擬核准「含單株抗體」新產品上市 (119) (0)
2013-07-16 置頂 歐盟修法 打造優質臨床試驗環境 (228) (0)
2013-05-27 置頂 催化醫材產業發展 新加坡HSA推出新快速上市審查方案 (103) (0)
2013-05-27 置頂 縮減病患近用新醫療器材時程~新加坡HSA推出新快速上市審查程序 (339) (0)
2013-03-17 置頂 歐盟高風險醫材規範已落伍 亟待補強? (41) (0)
2013-03-12 置頂 加速學名藥品近用? 歐盟議會支持新指令立法建議案 (42) (0)
2013-01-11 置頂 FDA為醫療器材產業築基~擬借公/私合作以促其法規科學研究發展 (47) (0)
2012-12-06 置頂 歐盟藉新指引 奪回全球生物相似性藥品的發球權? (79) (0)
2012-11-22 置頂 歐盟健康照護體制需徹底改革? 歐洲衛生論壇敲警鐘 (41) (0)
2012-11-13 置頂 歐洲下階段醫療技術發展 個人化醫療深受矚目 (83) (0)
2012-11-04 置頂 剖析合成生物學 管理法規新趨勢 (93) (0)
2012-09-04 置頂 歐洲境內臨床試驗申請案件量正逐年下滑? 法規遵循成本之影響似不容覷 (91) (0)
2012-08-01 置頂 歐盟公布新一波再生醫療產品管理規範 (213) (0)
2012-06-05 置頂 歐盟與印度將於年底完成FTA協商？低價藥品近用權益之衡平與保障仍是關鍵 (134) (0)
2012-05-17 置頂 FDA生物相似性蛋白質藥草案引發各界關注 (141) (0)
2012-05-09 置頂 歐洲生物相似性藥品 擬集中化上市 (23) (0)
2012-04-18 置頂 保障大眾醫療與用藥安全 FDA動作頻頻 (52) (0)
2012-02-11 置頂 生物辨識須兼顧隱私權及資訊自決權 (267) (0)
2012-01-10 置頂 CAM醫療驟增 美國將不再坐視? (39) (0)
2011-12-21 置頂 TFDA ANNOUNCED THE CRITERIA FOR CLINICAL TRIAL TO STRENGTHEN DOMESTIC SOMATIC CELL-BASED THERAPEUTIC PRODUCT (13) (0)
2011-12-21 置頂 TAIWAN AND CHINA SIGNED THE MEDICAL HEALTH COOPERATION AGREEMENT (12) (0)
2011-10-31 置頂 國際間科學專家利益衝突管理規範趨向~以美、歐藥品審查機構科學諮詢委員會專家利益衝突解決政策與機制為例 (47) (0)
2011-10-28 置頂 2011/09/02中山醫學大學附設醫院~人體臨床試驗「倫理、科學、法規與GCP (六)」 (84) (0)
2011-08-01 置頂 為保障大眾健康 FDA將阻撓IVDMIAs發展？ (41) (0)
2014-10-22 Collagen type 21 alpha 1 gene polymorphism in patients with cardiovascular diseases (15) (0)
2013-10-26 打擊生物瓢竊~歐盟議會支持新規則草案 (21) (0)
2013-10-26 EMA公布新修正版生物相似性藥品指引文件 (43) (0)
2011-12-30 FDA日前對境內營養補充品製造商採取正式法律行動 (44) (0)
2011-12-25 授權學名藥策略對藥品市場影響~FTC報告書(2011) (179) (0)
2011-12-21 TO PROMOTE DOMESTIC ENTERPRISES TO PARTICIPATE THE EUROPEAN RESEARCH PROJECT, GOVERNMENT BRINGS UP A NEW MULTILATERAL EUROPEAN INNOVATIVE R&D PROGRAMME (5) (0)
2011-12-21 THE MINISTRY OF ECONOMIC AFFAIRS (MOEA) PROMULGATED SUBSIDY REGULATIONS FOR PROMOTING RESEARCH INSTITUTES TO CONDUCT INDUSTRIAL INNOVATION AND RESEARCH AND DEVELOPMENT AND ASSISTING IN INDUSTRIAL INNOVATION ACTIVITIES, REPEALED THE FORMER REGULATIONS (20) (0)
2011-12-21 THE GOVERNMENT PLANED TO PROMOTE THE NEW ENERGY INDUSTRY BY SUBSIDIZATION AND EXEMPTION OF COMMODITY TAX (5) (0)
2011-12-21 THE TAIWAN FOOD AND DRUG ADMINISTRATION WILL BE ESTABLISHED (6) (0)
2011-12-21 TO AMEND THE GOVERNMENT PROCUREMENT ACT FOR PROMOTE THE EFFICIENCY OF PROCUREMENT PROCESS (7) (0)
2011-12-21 THE TAIWAN FOOD AND DRUG ADMINISTRATION WILL BE ESTABLISHED (7) (0)
2011-12-21 THE DRAFT STATUTE ON EMBRYONIC STEM CELL HAS PASSED FOR WHICH HUMAN CLONE WILL BE STRICTLY FORBIDDEN BY THE GOVERNMENT (2) (0)
2011-12-21 NEW GOVERNMENT HAS EASED LEGAL RESTRICTIONS TO SUPPORT THE INVESTMENT IN MAINLAND CHINA SINCE AUGUST 1ST (5) (0)
2011-12-21 DEALING WITH THE REPEAL OF THE STATUTE FOR UPGRADING INDUSTRIES, THE NEW GOVERNMENT EXPECTS TO COMPLETE THE LEGISLATION DURING NEXT YEAR (3) (0)
2011-12-21 THE ERA OF PROFESSIONALLY HANDLING INTELLECTUAL PROPERTY RIGHTS LITIGATIONS IS COMING (2) (0)
2011-12-21 THE INTELLECTUAL PROPERTY OFFICE OF MINISTRY OF ECONOMIC AFFAIRS ANNOUNCED THE DIRECTION OF AMENDMENT OF PATENT LAW IN THE FUTURE (9) (0)
2011-12-21 THE MANAGEMENT POLICY OF GENETICALLY MODIFIED ORGANISMS HAS BEEN ANNOUNCED (8) (0)
2011-12-01 沙漠中的玫瑰~談以色列鼓勵產業研發措施及其策略 (62) (0)
2011-11-28 FDA提出新指引草案以協助醫療器材人體試驗之進行 (35) (0)
2011-11-23 FTC日前公布授權學名藥策略對美國藥品市場影響之最終評估報告 (317) (0)
2011-11-14 歐盟擬提出「促進再生能源利用架構指令」以加速並規範未來境內生質能源與其他再生能源的整合與發展 (96) (0)
2011-10-31 歐盟藥品專利訴訟和解協議管理新近發展 (9) (0)
2011-10-30 美國藥品專利訴訟和解協議規範管理趨向 (33) (0)
2011-10-30 我國細胞治療產品法規範初探~以美歐法規範為借鏡 (26) (0)
2011-10-30 加拿大生技仿效藥品未來規範趨向 (41) (0)
«12 3